MOTS-c is an unregulated research compound, FDA-ineligible for compounding, and prohibited by WADA under S4.4.1 (AMPK activators)
SLU-PP-332's pharmacological positioning is that of a **synthetic agonist of all three paralogs ERRalpha, beta, gamma** (Estrogen-Related Receptors), orphan nuclear receptors discovered by Vincent Giguere in 1988
Aureane-type sesquiterpene tetraketides inhibit IL-17A secretion by downregulating the transcription factor RORt, and target and inhibit the glycolysis and gluconeogenesis pathways to block energy metabolism in Th17 cells, thereby improving inflammatory responses and vascular smooth muscle cell proliferation in PH (Tang et al., 2023)
The 10-day flight will help confirm systems and hardware needed for early human lunar exploration missions. NASA also has announced that an Artemis III mission is planned to launch in 2027, where astronauts will land on the moon for the first time, since the Apollo Program, more than 50 years ago
Gastrointestinal symptoms including nausea, decreased appetite, and altered bowel habitsare among the most common side effects during active treatment
Lets Talk Have you used GHK-Cu